previous compound ID: 2629 next compound
InChIKey: XQZXYNRDCRIARQ-LURJTMIESA-N
SMILES: C[C@@H](C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "J Goepp" "R Robert" "DY Thomas" "J Liao" "E Matthes" "GW Carlile" "B Kus" "JW Hanrahan" "D Rotin"

chemical graph of compound 2629





CID is 65492
synonyms found at PubChem are:
iopamidol, Iopamiron, 60166-93-0, Iopamiro, Isovue, Niopam, Solutrast, Gastromiro, Iopamidol 300, Solutrast 370, Iopamidolum, Oypalomin, Isovue 370, Iopamiron 300, Iopamiron 370, Jopamiron 200, Iopamiro 370, Isovue-370, Niopam 300, iomapidol, Iopamidolum [INN-Latin], UNII-JR13W81H44, B-15000, EINECS 262-093-6, B 15000, BRN 6250226, SQ 13396, SQ-13396, (S)-N,N'-bis(2-Hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodo-5-lactamidoisophthalamide, L-(+)-N,N'-Bis(2-hydroxy-1-hydroxymethylethyl)-2,4,6-triiodo-5-lactamide isophthalamide, L-5alpha-Hydroxypropionylamino-2,4,6-triiodoisophthalic acid di(1,3-dihydroxy-2-propylamide), CHEBI:31711, JR13W81H44, 62883-00-5, NCGC00016892-01, CAS-60166-93-0, DSSTox_CID_3158, DSSTox_RID_76896, L-5alpha-Idrossipropionilamino-2,4,6-triiodoisoftal-di(1,3-diidrossi-2-propilamide), DSSTox_GSID_23158, (S)-N,N'-Bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodoisophthaldiamide, 1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(((2S)-2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-, 1,3-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-, (S)-, 1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide, N,N'-bis(1,3-dihydroxypropan-2-yl)-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide, Iopamidol-200, Iopamidol-250, Iopamidol-300, Iopamidol-370, Scanlux-300, Scanlux-370, Isovue-128, Isovue-200, Isovue-250, Isovue-300, Isovue-M 200, Isovue-M 300, Iopamyron, Jopamiro, HSDB 8075, (S)-N,N'-Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-5-lactamidoisophthalamide, Iopamidol [USAN:INN:BAN:JAN], Iopamiron (TN), Iopamidol-200 in plastic container, Iopamidol-250 in plastic container, Iopamidol-300 in plastic container, Iopamidol-370 in plastic container, Isovue (TN), Iopamidol [USAN:USP:INN:BAN:JAN], SQ 13,396, AC1Q4PBP, Prestwick0_000871, Prestwick1_000871, Prestwick2_000871, Prestwick3_000871, Iopamidol (JP17/USP), D0O2HQ, AC1L23CM, Iopamidol injection (JP17), SCHEMBL27781, BSPBio_000941, SPBio_002862, BPBio1_001037, CHEMBL1200932, DTXSID1023158, MolPort-003-848-224, XQZXYNRDCRIARQ-LURJTMIESA-N, HMS1570P03, HMS2097P03, HMS3714P03, Pharmakon1600-01502304, ACT03261, HY-B0684, ZINC3830947, Tox21_110668, GP4065, NSC759636, s4532, AKOS015891034, Tox21_110668_1, API0003016, CCG-213024, CS-2917, DB08947, KS-1421, NSC-759636, NCGC00016892-02, NCGC00016892-04, AN-39478, CC-29575, LS-29730, SC-43948, AB00513941, FT-0627281, D01797, hydroxypropanamido)-2,4,6-triiodoisophthalamide, AB00513941_02, 166I930, C-23510, I01-8407, Q-201245, (S)-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(2-, BRD-K75868704-001-01-2, (S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide, (S)-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triiodoisophthalamide, N,N inverted exclamation mark -Bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxy-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxamide, N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-{[(2S)-2-hydroxypropanoyl]amino}-2,4,6-triiodobenzene-1,3-dicarboxamide, N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-[(2S)-2-hydroxypropanamido]-2,4,6-triiodobenzene-1,3-dicarboxamide, N1,N3-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodo-benzene-1,3-dicarboxamide